eConsent

Join Castor in Barcelona at SCOPE Europe 2024. Meet Tom Kiersey to discover our EDC, RWE, ePRO, eCOA, and eConsent solutions.

Meet the team at Biofuture to discuss your RWE needs, get a demo and see our newest human-in-the-loop AI capability in action.

One is very common, the other is rarely granted. Learn the key differences between waiver of consent & waiver of written consent for clinical trials

Exploring how early engagement with trial participants through an AI enabled chatbot can enhance both comprehension and satisfaction. 

eConsent regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 24 countries on use of eSignature and eConsent in clinical trials.

To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address the complexities of adoption, integration, and compliance measures

This product spotlight webinar will help you gain a deeper understanding of Castor’s eConsent capabilities for patients, sponsors and sites.

At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical and medical device companies remains a consideration for implementation teams.